| 1 | [SID103417331] | Active | IC50 | 17.2 | Inhibition of ABCG2 expressed in human NCI-H460 cells assessed as inhibition of PhA accumulation after 2 to 20 hrs relative to fumitremorgin C [AID587298, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Active | | IC50 | 17.2 [uM] | | BioAssay | Inhibition of ABCG2 expressed in human NCI-H460 cells assessed as inhibition of PhA accumulation after 2 to 20 hrs relative to fumitremorgin C | | AID | 587298 | | BioAssay type | Literature | | Target | | | PubMed | 21275386 | | Data Table |  |
|
| 2 | [SID103417331] | Unspecified | | | Maximal non-toxic dose (MNTD) that shows antiviral activity. [AID162242, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Unspecified | | BioAssay | Maximal non-toxic dose (MNTD) that shows antiviral activity. | | AID | 162242 | | BioAssay type | Literature | | Target | | | PubMed | 1847431 | | Data Table |  |
|
| 3 | [SID103417331] | Unspecified | | | Minimum drug concentration at which 99% of the polio virus is inhibited [AID162238, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Unspecified | | BioAssay | Minimum drug concentration at which 99% of the polio virus is inhibited | | AID | 162238 | | BioAssay type | Literature | | Target | | | PubMed | 1847431 | | Data Table |  |
|
| 4 | [SID103417331] | Unspecified | | | Cytotoxic dose at which 50% growth of normal cells is inhibited [AID162237, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Unspecified | | BioAssay | Cytotoxic dose at which 50% growth of normal cells is inhibited | | AID | 162237 | | BioAssay type | Literature | | Target | | | PubMed | 1847431 | | Data Table |  |
|
| 5 | [SID103417331] | Unspecified | | | The ratio of the poliovirus viral titer of the virus control (reduction factor) to the viral titer in the presence of the maximal non-toxic dose (RF MNTD) [AID162244, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Unspecified | | BioAssay | The ratio of the poliovirus viral titer of the virus control (reduction factor) to the viral titer in the presence of the maximal non-toxic dose (RF MNTD) | | AID | 162244 | | BioAssay type | Literature | | Target | | | PubMed | 1847431 | | Data Table |  |
|
| 6 | [SID103417331] | Unspecified | | | Minimal dose which produces titer reduction at 10 ug/mL (mD RF10e3) [AID162249, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Unspecified | | BioAssay | Minimal dose which produces titer reduction at 10 ug/mL (mD RF10e3) | | AID | 162249 | | BioAssay type | Literature | | Target | | | PubMed | 1847431 | | Data Table |  |
|
| 7 | [SID103417331] | Unspecified | | | Therapeutic Index measured as the ratio of CyD50(polio) / ED99(polio) values [AID235260, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Unspecified | | BioAssay | Therapeutic Index measured as the ratio of CyD50(polio) / ED99(polio) values | | AID | 235260 | | BioAssay type | Literature | | Target | | | PubMed | 1847431 | | Data Table |  |
|
| 8 | [SID103417331] | Unspecified | IC50 | | Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced superoxide anion generation [AID319546, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced superoxide anion generation | | AID | 319546 | | BioAssay type | Literature | | Target | | | PubMed | 18163582 | | Data Table |  |
|
| 9 | [SID103417331] | Unspecified | | | Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced elastase release [AID319548, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Unspecified | | BioAssay | Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced elastase release | | AID | 319548 | | BioAssay type | Literature | | Target | | | PubMed | 18163582 | | Data Table |  |
|
| 10 | [SID103417331] | Inactive | | | Antimicrobial activity against Bacillus subtilis ATCC 6633 at 100 ug/mL by agar dilution assay [AID378629, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Inactive | | BioAssay | Antimicrobial activity against Bacillus subtilis ATCC 6633 at 100 ug/mL by agar dilution assay | | AID | 378629 | | BioAssay type | Literature | | Target | | | PubMed | 11141110 | | Data Table |  |
|
| 11 | [SID103417331] | Inactive | | | Antimicrobial activity against Candida albicans ATCC 10231 at 100 ug/mL by agar dilution assay [AID378630, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Inactive | | BioAssay | Antimicrobial activity against Candida albicans ATCC 10231 at 100 ug/mL by agar dilution assay | | AID | 378630 | | BioAssay type | Literature | | Target | | | PubMed | 11141110 | | Data Table |  |
|
| 12 | [SID103417331] | Inactive | | | Antimicrobial activity against Escherichia coli ATCC 25922 at 100 ug/mL by agar dilution assay [AID378631, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Inactive | | BioAssay | Antimicrobial activity against Escherichia coli ATCC 25922 at 100 ug/mL by agar dilution assay | | AID | 378631 | | BioAssay type | Literature | | Target | | | PubMed | 11141110 | | Data Table |  |
|
| 13 | [SID103417331] | Inactive | | | Antimicrobial activity against Mycobacterium smegmatis ATCC 35797 at 100 ug/mL by agar dilution assay [AID378632, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Inactive | | BioAssay | Antimicrobial activity against Mycobacterium smegmatis ATCC 35797 at 100 ug/mL by agar dilution assay | | AID | 378632 | | BioAssay type | Literature | | Target | | | PubMed | 11141110 | | Data Table |  |
|
| 14 | [SID103417331] | Inactive | | | Antimicrobial activity against Pseudomonas aeruginosa ATCC 15442 at 100 ug/mL by agar dilution assay [AID378633, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Inactive | | BioAssay | Antimicrobial activity against Pseudomonas aeruginosa ATCC 15442 at 100 ug/mL by agar dilution assay | | AID | 378633 | | BioAssay type | Literature | | Target | | | PubMed | 11141110 | | Data Table |  |
|
| 15 | [SID103417331] | Inactive | | | Antimicrobial activity against Staphylococcus aureus ATCC 29213 at 100 ug/mL by agar dilution assay [AID378634, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Inactive | | BioAssay | Antimicrobial activity against Staphylococcus aureus ATCC 29213 at 100 ug/mL by agar dilution assay | | AID | 378634 | | BioAssay type | Literature | | Target | | | PubMed | 11141110 | | Data Table |  |
|
| 16 | [SID103417331] | Inactive | | | In vivo antitumor activity against mouse L1210 cells [AID404069, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103417331 | | CID | 5281677 | | Outcome | Inactive | | BioAssay | In vivo antitumor activity against mouse L1210 cells | | AID | 404069 | | BioAssay type | Literature | | Target | | | PubMed | 469554 | | Data Table |  |
|